These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15528231)

  • 21. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat.
    Rajab P; Fox J; Riaz S; Tomlinson D; Ball D; Greenhaff PL
    Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1076-81. PubMed ID: 10956268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol.
    Kazanietz MG; Enero MA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):758-64. PubMed ID: 2156060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute inhibitory effects of clenbuterol on force, Ca²⁺ transients and action potentials in rat soleus may not involve the β₂-adrenoceptor pathway.
    Head SI; Ha TN
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):638-46. PubMed ID: 21752065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes.
    Tweedie D; Harding SE; MacLeod KT
    J Mol Cell Cardiol; 2000 Feb; 32(2):261-72. PubMed ID: 10722802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression.
    Wong K; Boheler KR; Petrou M; Yacoub MH
    Circulation; 1997 Oct; 96(7):2239-46. PubMed ID: 9337196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.
    Plant DR; Kearns CF; McKeever KH; Lynch GS
    J Muscle Res Cell Motil; 2003; 24(7):471-6. PubMed ID: 14677650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
    Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
    Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats.
    Duncan ND; Williams DA; Lynch GS
    Clin Sci (Lond); 2000 Mar; 98(3):339-47. PubMed ID: 10677393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clenbuterol Prevents Mechanical Unloading-Induced Myocardial Atrophy via Upregulation of Transient Receptor Potential Channel-3.
    Hu D; Li H; Yu H; Zhao M; Ye L; Liu B; Ge N; Dong N; Wu L
    Int Heart J; 2023; 64(5):901-909. PubMed ID: 37778993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-type Ca
    Deng WK; Wang X; Zhou HC; Luo F
    Mol Cell Neurosci; 2019 Dec; 101():103410. PubMed ID: 31644953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers.
    von Deutsch DA; Abukhalaf IK; Wineski LE; Aboul-Enein HY; Pitts SA; Parks BA; Oster RA; Paulsen DF; Potter DE
    Chirality; 2000 Aug; 12(8):637-48. PubMed ID: 10897101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells.
    Hüser J; Wang YG; Sheehan KA; Cifuentes F; Lipsius SL; Blatter LA
    J Physiol; 2000 May; 524 Pt 3(Pt 3):795-806. PubMed ID: 10790159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
    Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
    J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat.
    Choo JJ; Horan MA; Little RA; Rothwell NJ
    Metabolism; 1990 Jun; 39(6):647-50. PubMed ID: 1693748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone-augmented contractile responses to alpha1- and beta1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart.
    Tsang S; Wong SS; Wu S; Kravtsov GM; Wong TM
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C766-82. PubMed ID: 19336623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure.
    Lindner M; Erdmann E; Beuckelmann DJ
    J Mol Cell Cardiol; 1998 Apr; 30(4):743-9. PubMed ID: 9602423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
    Bovo E; Mazurek SR; Zima AV
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca flux, contractility, and excitation-contraction coupling in hypertrophic rat ventricular myocytes.
    McCall E; Ginsburg KS; Bassani RA; Shannon TR; Qi M; Samarel AM; Bers DM
    Am J Physiol; 1998 Apr; 274(4):H1348-60. PubMed ID: 9575940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy.
    Terracciano CM; Harding SE; Adamson D; Koban M; Tansley P; Birks EJ; Barton PJ; Yacoub MH
    Eur Heart J; 2003 Jul; 24(14):1329-39. PubMed ID: 12871690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.